신규 아실-코에이 : 콜레스테롤 아실전이효소(ACAT) 활성 저해물질 및 이의 제조 방법
    1.
    发明授权
    신규 아실-코에이 : 콜레스테롤 아실전이효소(ACAT) 활성 저해물질 및 이의 제조 방법 失效
    新型ACYL-COA:胆固醇ACYL-TRANSFERASE(ACAT)抑制剂及其制备方法

    公开(公告)号:KR100125129B1

    公开(公告)日:1997-11-28

    申请号:KR1019940019984

    申请日:1994-08-13

    Abstract: The present invention is related to new compounds, GERI-BP001 (C27H33NO5) which is acyl-CoA: cholesterol acyltransferase (ACAT) inhibitor separated from fungus Aspergillus fumigatus FM-F-37 isolated from the earth and its derivatives and to the method for preparation therof. The GERI-BP001 and its derivatives, GERI-BP001-A and GERI-BP001-B are useful for the treatment of hyperlipemia by inhibiting cholesterol trasferase in blood. The GERI-BP001 together its derivatives, GERI-BP001-A and GERI-BP001-B are separated and purified from cultures of Aspergillus sp. strains including Aspergillus fumigatus FM-F-37, GERI-BP001-C can be prepared chemically from GERI-BP001-A by means of nucleophilic substitution reactions.

    Abstract translation: 本发明涉及从分离自地球及其衍生物的真菌烟曲霉FM-F-37分离的酰基辅酶A:胆固醇酰基转移酶(ACAT)抑制剂GERI-BP001(C27H33NO5)和制备方法的新化合物 therof。 GERI-BP001及其衍生物GERI-BP001-A和GERI-BP001-B可用于通过抑制血液中的胆固醇trasferase来治疗高脂血症。 将GERI-BP001及其衍生物GERI-BP001-A和GERI-BP001-B从曲霉菌培养物中分离和纯化。 包括烟曲霉FM-F-37,GERI-BP001-C的菌株可以通过亲核取代反应由GERI-BP001-A化学制备。

Patent Agency Ranking